Involvement of Hypoxia-Inducible factors in the dysregulation of oxygen homeostasis in sepsis

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 15, Issue 1, 2015, Pages 29-40

  Hirota, Kiichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemokine; Cytokine; Hypoxia; Hypoxia inducible factor; Inflammation; NF B; Sepsis

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CD18 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOCHROME C OXIDASE; DEXAMETHASONE; E1A ASSOCIATED P300 PROTEIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; HYPOXIA INDUCIBLE FACTOR 3ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NITRIC OXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; UNINDEXED DRUG; VASCULOTROPIN; HYPOXIA INDUCIBLE FACTOR 1;

ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CELLS; ENDOTHELIAL DYSFUNCTION; GENE; GENE EXPRESSION; HEALING; HOMEOSTASIS; HUMAN; HYPOXEMIA; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; INFLAMMATION; INTENSIVE CARE; METABOLISM; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; SEPSIS; TISSUE INJURY; TRANSCRIPTION REGULATION; VASCULAR DISEASE; WOUND HEALING IMPAIRMENT; ANIMAL; CELL HYPOXIA; GENE EXPRESSION REGULATION; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CELL HYPOXIA; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATION; OXYGEN; SEPSIS;

EID: 84924135769     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X15666150108115553     Document Type: Article

References (99)

1. Hirota, K. Hypoxia and hypoxia-inducible factor in inflammation. In: Roy S, editor. Chronic Inflammation: Mole. Pathophysiol. Nutrit. Therap. Intervent. Taylor & Francis; 2012. p. 51-65.
2. Bone, R.C.; Balk, R.A.; Cerra, F.B.; Dellinger, R.P.; Fein, A.M.; Knaus, W.A.; Schein, R.M.; Sibbald, W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101, 1644-55.
3. Dellinger, R.P.; Levy, M.M.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, S.M.; Sevransky, J.E.; Sprung, C.L.; Douglas, I.S.; Jaeschke, R.; Osborn, T.M.; Nunnally, M.E.; Townsend, S.R.; Reinhart, K.; Kleinpell, R.M.; Angus, D.C.; Deutschman, C.S.; Machado, F.R.; Rubenfeld, G.D.; Webb, S.A.; Beale, R.J.; Vincent, J.L.; Moreno, R.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric S. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med., 2013, 41, 580-637.
4. Vodovotz, Y.; Billiar, T.R. In silico modeling: methods and applications to trauma and sepsis. Crit. Care Med., 2013, 41, 2008- 14.
5. Evans, T.W.; Smithies, M. ABC of intensive care: organ dysfunction. BMJ, 1999, 318, 1606-9.
6. Russell JA. Management of sepsis. N. Engl. J. Med., 2006, 355, 1699-713.
7. Lee, W.L.; Slutsky, A.S. Sepsis and endothelial permeability. N. Engl. J. Med., 2010, 363, 689-91.
8. Williams, S.C.P. After Xigris, researchers look to new targets to combat sepsis. Nat. Med., 2012 Jul;Sect. 1001.
9. Zinkernagel, A.S.; Johnson, R.S.; Nizet, V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J. Mol., 2007, 85, 1339-46.
10. Hayden, W.R. Sepsis and organ failure definitions and guidelines. Crit. Care Med., 1993, 21, 1612-3.
11. Ranieri, V.M.; Rubenfeld, G.D.; Thompson, B.T.; Ferguson, N.D.; Caldwell, E.; Fan, E.; Camporota, L.; Slutsky, A.S. Acute respiratory distress syndrome: the Berlin Definition. 2012, 307, 2526-33.
12. Medzhitov, R. Origin and physiological roles of inflammation. Nature, 2008, 454, 428-35.
13. Weiss, U. Inflammation. Nature, 2008, 454, 427.
14. Dehne, N.; Brune, B. HIF-1 in the inflammatory microenvironment. Exp. Cell Res., 2009, 315, 1791-7.
15. Riedemann, N.C.; Guo, R.F.; Ward, P.A. The enigma of sepsis. J. Clin. Invest., 2003, 112, 460-7.
16. Reinhart, K.; Bayer, O.; Brunkhorst, F.; Meisner, M. Markers of endothelial damage in organ dysfunction and sepsis. Crit. Care Med., 2002, 30, S302-12.
17. London, N.R.; Zhu, W.; Bozza, F.A.; Smith, M.C.P.; Greif, D.M.; Sorensen, L.K.; Chen, L.; Kaminoh, Y.; Chan, A.C.; Passi, S.F.; Day, C.W.; Barnard, D.L.; Zimmerman, G.A.; Krasnow, M.A.; Li, D.Y. Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci. Transl. Med., 2010, 2, 23-19.
18. Jones, C.A.; London, N.R.; Chen, H.; Park, K.W.; Sauvaget, D.; Stockton, R.A.; Wythe, J.D.; Suh, W.; Larrieu-Lahargue, F.; Mukouyama, Y-S.; Lindblom, P.; Seth, P.; Frias, A.; Nishiya, N.; Ginsberg, M.H.; Gerhardt, H.; Zhang, K.; Li, D.Y. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med., 2008, 14, 448-53.
19. Ince, C. The microcirculation unveiled. Am. J. Respir. Crit. Care Med., 2002, 166, 1-2.
20. Tyagi, A.; Sethi, A.K.; Girotra, G.; Mohta, M. The microcirculation in sepsis. Indian J. Anaesth., 2009, 53, 281-93.
21. Lehr, H.A.; Bittinger, F.; Kirkpatrick, C.J. Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy? J. Pathol., 2000, 190, 373-86.
22. Eltzschig, H.K.; Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med., 2011, 364, 656-65.
23. Eltzschig, H.K. Targeting Hypoxia-induced Inflammation. Anesthesiology, 2011, 114, 239-42.
24. Fink, M.P. Bench-to-bedside review: Cytopathic hypoxia. Crit. Care, 2002, 6, 491-9.
25. Semenza, G.L. Life with oxygen. Science, 2007, 318, 62-4.
26. Weir, E.K.; Lopez-Barneo, J.; Buckler, K.J.; Archer, S.L. Acute oxygen-sensing mechanisms. N. Engl. J. Med., 2005, 353,2042-55.
27. Kruger, B.; Krick, S.; Dhillon, N.; Lerner, S.M.; Ames, S.; Bromberg, J.S.; Lin, M.; Walsh, L.; Vella, J.; Fischereder, M.; Kramer, B.K.; Colvin, R.B.; Heeger, P.S.; Murphy, B.T.; Schroppel, B. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. USA, 2009, 106, 3390-5.
28. Ferguson, N.D.; Fan, E.; Camporota, L.; Antonelli, M.; Anzueto, A.; Beale, R.; Brochard, L.; Brower, R.; Esteban, A.; Gattinoni, L.; Rhodes, A.; Slutsky, A.S.; Vincent, J.L.; Rubenfeld, G.D.; Thompson, B.T.; Ranieri, V.M. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Inten. Care Med., 2012, 38, 1573-82.
29. Suganami, T.; Ogawa, Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J. Leukoc. Biol., 2010, 88, 33-9.
30. Grocott, M.; Montgomery, H.; Vercueil, A. High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine. Crit. Care., 2007, 11, 203.
31. Richard, N.A.; Sahota, I.S.; Widmer, N.; Ferguson, S.; Sheel, A.W.; Koehle, M.S. Acute Mountain Sickness, Chemosensitivity and Cardio-Respiratory Responses in Humans Exposed to Hypobaric and Normobaric Hypoxia. J. Appl. Physiol., 2014, 116(7), 945-52
32. Peacock AJ. ABC of oxygen: oxygen at high altitude. BMJ. 1998, 317, 1063-6.
33. Grocott, M.P.; Martin, D.S.; Levett, D.Z.; McMorrow, R.; Windsor, J.; Montgomery, H.E.; Caudwell Xtreme Everest Research G. Arterial blood gases and oxygen content in climbers on Mount Everest. N. Engl. J. Med., 2009, 360, 140-9.
34. Hirota, K. Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression. J. Anesth., 2002, 16, 150-9.
35. Wang, G.; Jiang, B.; Rue, E.; Semenza, G. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA., 1995, 92, 5510-4.
36. Semenza, G.L. Oxygen sensing, homeostasis, and disease. N. Engl. J. Med., 2011, 365, 537-47.
37. Manalo, D.J.; Rowan, A.; Lavoie, T.; Natarajan, L.; Kelly, B.D.; Ye, S.Q.; Garcia, J.G.; Semenza, GL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood, 2005, 105, 659-69.
38. Hirota, K.; Semenza, G.L. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem. Biophys. Res. Commun., 2005, 338, 610-6.
39. Schofield, C.J.; Ratcliffe, P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol., 2004, 5, 343-54.
40. Kaelin, W.G.; Jr., Ratcliffe, P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell., 2008, 30, 393-402.
41. Epstein, A.; Gleadle, J.; McNeill, L.; Hewitson, K.; O'Rourke, J.; Mole, D.; Mukherji, M.; Metzen, E.; Wilson, M.; Dhanda, A.; Tian, Y.; Masson, N.; Hamilton, D.; Jaakkola, P.; Barstead, R.; Hodgkin, J.; Maxwell, P.; Pugh, C.; Schofield, C.; Ratcliffe, P.C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 2001, 107, 43-54.
42. Lando, D.; Peet, D.J.; Gorman, J.J.; Whelan, D.A.; Whitelaw, M.L.; Bruick, R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev., 2002, 16, 1466-71.
43. Mahon, P.C.; Hirota, K.; Semenza, G.L. FIH-1: a novel protein that interacts with HIF-1a and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev., 2001, 15, 2675-86.
44. Maxwell, P.H.; Wiesener, M.S.; Chang, G.W.; Clifford, S.C.; Vaux, E.C.; Cockman, M.E.; Wykoff, C.C.; Pugh, C.W.; Maher, E.R.; Ratcliffe, P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 1999, 399, 271-5.
45. Mimura, I.; Kanki, Y.; Kodama, T.; Nangaku, M. Revolution of nephrology research by deep sequencing: ChIP-seq and RNA-seq. Kidney Int., 2014, 85, 31-8.
46. Mimura, I.; Nangaku, M.; Kanki, Y.; Tsutsumi, S.; Inoue, T.; Kohro, T.; Yamamoto, S.; Fujita, T.; Shimamura, T.; Suehiro, J.; Taguchi, A.; Kobayashi, M.; Tanimura, K.; Inagaki, T.; Tanaka, T.; Hamakubo, T.; Sakai, J.; Aburatani, H.; Kodama, T.; Wada, Y. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A. Mol. Cell Biol., 2012, 32, 3018-32.
47. Semenza, G.L.; Prabhakar, N.R. HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid. Redox Signal., 2007, 9, 1391-6.
48. Semenza, G.L.; Prabhakar, N.R. The role of hypoxia-inducible factors in oxygen sensing by the carotid body. Adv. Exp. Med. Biol., 2012, 758, 1-5.
49. Prabhakar, N.R.; Semenza, G.L. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol. Rev., 2012, 92, 967-1003.
50. Prabhakar, N.R.; Kumar, G.K.; Nanduri, J.; Semenza, G.L. ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid. Redox Signal., 2007, 9, 1397-403.
51. Hellwig-Burgel, T.; Rutkowski, K.; Metzen, E.; Fandrey, J.; Jelkmann, W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood, 1999, 94, 1561-7.
52. Richard, D.E.; Berra, E.; Pouyssegur, J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem., 2000, 275, 26765-71.
53. Nishi, K.; Oda, T.; Takabuchi, S.; Oda, S.; Fukuda, K.; Adachi, T.; Semenza, G.L.; Shingu, K.; Hirota, K. LPS induces hypoxiainducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid. Redox Signal., 2008, 10, 983-96.
54. Kasuno, K.; Takabuchi, S.; Fukuda, K.; Kizaka-Kondoh, S.; Yodoi, J.; Adachi, T.; Semenza, G.L.; Hirota, K. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling. J. Biol. Chem., 2004, 279, 2550-8.
55. Hagen, T.; Taylor, C.T.; Lam, F.; Moncada, S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science, 2003, 302, 1975-8.
56. Gerald, D.; Berra, E.; Frapart, Y.M.; Chan, D.A.; Giaccia, A.J.; Mansuy, D.; Pouyssegur, J.; Yaniv, M.; Mechta-Grigoriou, F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell., 2004, 118, 781-94.
57. Cummins, E.P.; Taylor, C.T. Hypoxia-responsive transcription factors. Pflugers Arch., 2005, 450, 363-71.
58. Taylor, C.T. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J. Physiol., 2008, 586, 4055-9.
59. Walmsley, S.R.; Print, C.; Farahi, N.; Peyssonnaux, C.; Johnson, R.S.; Cramer, T.; Sobolewski, A.; Condliffe, A.M.; Cowburn, A.S.; Johnson, N.; Chilvers, E.R. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J. Exp. Med., 2005, 201, 105-15.
60. Rius, J.; Guma, M.; Schachtrup, C.; Akassoglou, K.; Zinkernagel, A.S.; Nizet, V.; Johnson, R.S.; Haddad, G.G.; Karin, M. NFkappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature, 2008, 453, 807- 11.
61. Walmsley, S.R.; Cadwallader, K.A.; Chilvers, E.R. The role of HIF-1alpha in myeloid cell inflammation. Trends Immunol., 2005, 26, 434-9.
62. Zarember, K.A.; Malech, H.L. HIF-1alpha: a master regulator of innate host defenses? J. Clin. Invest., 2005, 115, 1702-4.
63. Strieter, R.M. Mastering innate immunity. Nat. Med., 2003, 9, 512- 3.
64. Cramer, T.; Yamanishi, Y.; Clausen, B.E.; Forster, I.; Pawlinski, R.; Mackman, N.; Haase, V.H.; Jaenisch, R.; Corr, M.; Nizet, V.; Firestein, G.S.; Gerber, H.P.; Ferrara, N.; Johnson, R.S. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell, 2003, 112, 645-57.
65. Cramer, T.; Johnson, R.S. A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of inflammatory cell function. Cell Cycle., 2003, 2, 192-3.
66. Serhan, C.N.; Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol., 2005, 6,1191-7.
67. Walmsley, S.R.; Chilvers, E.R.; Thompson, A.A.; Vaughan, K.; Marriott, H.M.; Parker, L.C.; Shaw, G.; Parmar, S.; Schneider, M.; Sabroe, I.; Dockrell, D.H.; Milo, M.; Taylor, C.T.; Johnson, R.S.; Pugh, C.W.; Ratcliffe, P.J.; Maxwell, P.H.; Carmeliet, P.; Whyte, M.K.B. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J. Clin. Invest., 2011, 121,1053-63.
68. Kong, T.; Eltzschig, H.K.; Karhausen, J.; Colgan, S.P.; Shelley, C.S. Leukocyte adhesion during hypoxia is mediated by HIF-1- dependent induction of beta2 integrin gene expression. Proc. Natl. Acad. Sci. USA, 2004, 101, 10440-5.
69. Oda, T.; Hirota, K.; Nishi, K.; Takabuchi, S.; Oda, S.; Yamada, H.; Arai, T.; Fukuda, K.; Kita, T.; Adachi, T.; Semenza, G.L.; Nohara, R. Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am. J. Physiol. Cell Physiol., 2006, 291, C104-C13.
70. Spirig, R.; Djafarzadeh, S.; Regueira, T.; Shaw, S.G.; von Garnier, C.; Takala, J.; Jakob, S.M.; Rieben, R.; Lepper, P.M. Effects of TLR agonists on the hypoxia-regulated transcription factor HIF- 1alpha and dendritic cell maturation under normoxic conditions. PLoS ONE, 2010, 5, e0010983.
71. Jantsch, J.; Chakravortty, D.; Turza, N.; Prechtel, A.T.; Buchholz, B.; Gerlach, R.G.; Volke, M.; Glasner, J.; Warnecke, C.; Wiesener, M.S.; Eckardt, K.U.; Steinkasserer, A.; Hensel, M.; Willam, C. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J. Immunol., 2008, 180, 4697-705.
72. Dang, E.V.; Barbi, J.; Yang, H.Y.; Jinasena, D.; Yu, H.; Zheng, Y.; Bordman, Z.; Fu, J.; Kim, Y.; Yen, H.R.; Luo, W.; Zeller, K.; Shimoda, L.; Topalian, S.L.; Semenza, G.L.; Dang, C.V.; Pardoll, D.M.; Pan, F. Control of T(H)17/T(reg) Balance by Hypoxia- Inducible Factor 1. Cell, 2011, 146, 772-84.
73. Shi, L.Z.; Wang, R.; Huang, G.; Vogel, P.; Neale, G.; Green, D.R.; Chi, H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med., 2011, 208, 1367-76.
74. Woodman, I. T cells: a metabolic sHIFt to turn 17. Nat. Rev. Immunol., 2011, 11, 503.
75. Makino, Y.; Nakamura, H.; Ikeda, E.; Ohnuma, K.; Yamauchi, K.; Yabe, Y.; Poellinger, L.; Okada, Y.; Morimoto, C.; Tanaka, H. Hypoxia-inducible factor regulates survival of antigen receptordriven T cells. J. Immunol., 2003, 171, 6534-40.
76. Nakamura, H.; Makino, Y.; Okamoto, K.; Poellinger, L.; Ohnuma, K.; Morimoto, C.; Tanaka, H. TCR engagement increases hypoxiainducible factor-1 alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J. Immunol., 2005, 174,7592-9.
77. Lee, K.S.; Kim, S.R.; Park, S.J.; Min, K.H.; Lee, K.Y.; Choe, Y.H.; Park, S.Y.; Chai, O.H.; Zhang, X.; Song, C.H.; Lee, Y.C. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. Am. J. Respir. Crit. Care Med., 2008, 178, 787-97.
78. Herold, S.; Gabrielli, N.M.; Vadasz, I. Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol., 2013, 305, L665-81.
79. Leach, R.M.; Treacher, D.F. ABC of Oxygen: Oxygen transport-2. Tissue hypoxia. BMJ., 1998, 317, 1370-3.
80. Textoris, J.; Beaufils, N.; Quintana, G.; Lassoud, A.B.; Zieleskiewicz, L.; Wiramus, S.; Blasco, V.; Lesavre, N.; Martin, C.; Gabert, J.; Leone, M. Hypoxia-inducible factor (HIF1alpha) gene expression in human shock states. Crit. Care., 2012, 16, R120.
81. Xing, K.; Murthy, S.; Liles, W.C.; Singh, J.M. Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review. Crit. Care., 2012, 16, R7.
82. Chen, F.; Kondo, N.; Sonobe, M.; Fujinaga, T.; Wada, H.; Bando, T. Expression of endothelial cell-specific adhesion molecules in lungs after cardiac arrest. Interact. Cardiovasc. Thorac. Surg., 2008, 7, 437-40.
83. Paulus, P.; Jennewein, C.; Zacharowski, K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers, 2011, 16, S11-21.
84. Peyssonnaux, C.; Cejudo-Martin, P.; Doedens, A.; Zinkernagel, A.S.; Johnson, R.S.; Nizet, V. Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J. Immunol., 2007, 178, 7516-9.
85. Fraisl, P.; Aragones, J.; Carmeliet, P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat. Rev. Drug Discov., 2009, 8, 139-52.
86. Wagner, A.E.; Huck, G.; Stiehl, D.P.; Jelkmann, W.; Hellwig- Burgel, T. Dexamethasone impairs hypoxia-inducible factor-1 function. Biochem. Biophys. Res. Commun., 2008, 372, 336-40.
87. Albini, A.; Tosetti, F.; Li, V.W.; Noonan, D.M.; Li, W.W. Cancer prevention by targeting angiogenesis. Nat. Rev. Clin. Oncol., 2012, 9, 498-509.
88. Palayoor, S.T.; Tofilon, P.J.; Coleman, C.N. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Clin. Cancer Res., 2003, 9, 3150-7.
89. Lee, S.H.; Kim, M.H.; Han, H.J. Arachidonic acid potentiates hypoxia-induced VEGF expression in mouse embryonic stem cells: involvement of Notch, Wnt, and HIF-1alpha. Am. J. Physiol Cell Physiol., 2009, 297, C207-16.
90. Wang, J.; Wu, K.; Bai, F.; Zhai, H.; Xie, H.; Du, Y.; Liang, J.; Han, S.; Chen, Y.; Lin, T.; Fan, D. Celecoxib could reverse the hypoxiainduced Angiopoietin-2 upregulation in gastric cancer. Cancer Lett., 2006, 242, 20-7.
91. Takabuchi, S.; Hirota, K.; Nishi, K.; Oda, S.; Oda, T.; Shingu, K.; Takabayashi, A.; Adachi, T.; Semenza, G.L.; Fukuda, K. The intravenous anesthetic propofol inhibits hypoxia-inducible factor 1 activity in an oxygen tension-dependent manner. FEBS letters., 2004, 577, 434-8.
92. Yeh, C.H.; Cho, W.; So, E.C.; Chu, C.C.; Lin, M.C.; Wang, J.J.; Hsing, C.H. Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1alpha expression. Br. J. Anaesth., 2011, 106, 590-9.
93. Brune, B.; Zhou, J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc. Res., 2007, 75, 275-82.
94. Li, F.; Sonveaux, P.; Rabbani, Z.N.; Liu, S.; Yan, B.; Huang, Q.; Vujaskovic, Z.; Dewhirst, M.W.; Li, C.Y. Regulation of HIF 1alpha stability through S-nitrosylation. Mol. Cell., 2007, 26 , 63- 74.
95. Pan, J.; Mestas, J.; Burdick, M.D.; Phillips, R.J.; Thomas, G.V.; Reckamp, K.; Belperio, J.A. Strieter, R.M. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol. Can., 2006, 5, 56.
96. Oda, S.; Oda, T.; Nishi, K.; Takabuchi, S.; Wakamatsu, T.; Tanaka, T.; Adachi, T.; Fukuda, K.; Semenza, G.L.; Hirota, K. Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS ONE, 2008, 3, e2215.
97. Gorlach, A.; Diebold, I.; Schini-Kerth, V.B.; Berchner- Pfannschmidt, U.; Roth, U.; Brandes, R.P.; Kietzmann, T.; Busse, R. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)- containing NADPH oxidase. Cir. Res., 2001, 89, 47-54.
98. Fukuda, R.; Kelly, B.; Semenza, G.L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res., 2003, 63, 2330-4.
99. Ohh, M.; Park, C.W.; Ivan, M.; Hoffman, M.A.; Kim, T.Y.; Huang, L.E.; Pavletich, N.; Chau, V.; Kaelin, W.G. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol., 2000, 2, 423-7.